9 January 2019
Orowealth, one of India’s leading Direct Mutual Fund platforms, today announced that it has acquired the WealthTrust platform, including the product and all its users. Orowealth is a cutting edge investment platform with award winning advisory services. It seeks to be a one-stop solution for all your investment needs — from investing in stocks and direct mutual funds, to financial planning, goal advisory and more. WealthTrust, also one of the India’s fastest growing ‘Zero Commission Wealth Management’ platforms, always aimed to make investment simple and hassle-free.
Mr. Nisarg Gandhi, Co-founder and CEO of WealthTrust, said that the WealthTrust team evaluated several partners before partnering with Orowealth, which stood out as the best option for their users. “We are confident that our clients will be in good hands as Orowealth has a proven track record of rewarding investors through a diverse line-up of award winning products,” he further added.
Mr. Jasmin Gohil – Co-founder and CTO at WealthTrust commented that the WealthTrust technology stack will complement Orowealth’s Advisory prowess, creating an industry-leading solution for wealth management.
The two companies now have a combined user base of 3 lakh registered users, and their assets under advisory (AUA) will be over 2000 crores.
Speaking about the announcement, Mr. Vijay Kuppa, Co-Founder of Orowealth said, “As a Direct Mutual Fund investment platform, we are always seeking opportunities to strategically grow our business. We are very pleased to have the opportunity to service WealthTrust customers, and will offer them the same industry-leading advisory and wealth management services that we provide to our own users.”
A select team of WealthTrust employees is expected to join Orowealth as part of the acquisition. Their main aim will be to transition their users seamlessly to the Orowealth platform. Meanwhile, WealthTrust assures its customers that their investments are 100% secure, and that this merger will in no way hinder their investment journey.